These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5714889)

  • 21. THE EFFECTS OF CHLOROPHENOXYISOBUTYRATE WITH AND WITHOUT ANDROSTERONE ON THE SERUM LIPIDS, FAT TOLERANCE, AND URIC ACID.
    BERKOWITZ D
    Metabolism; 1965 Sep; 14():966-75. PubMed ID: 14327273
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of clofibrate (Atromid S) on the thyroxine-binding capacity of thyroxine-binding globulin and free thyroxine.
    McKerron CG; Scott RL; Asper SP; Levy RI
    J Clin Endocrinol Metab; 1969 Jul; 29(7):957-61. PubMed ID: 4978385
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of hypocholesteremic agents on myelinogenesis.
    Fumagalli R; Smith ME; Urna G; Paoletti R
    J Neurochem; 1969 Sep; 16(9):1329-39. PubMed ID: 5808099
    [No Abstract]   [Full Text] [Related]  

  • 24. [Influence of beta-benzabutyramide on the blood lipids and on the thrombodensitogram].
    Ferri F; Regazzini A; Pedini G
    G Gerontol; 1970 Mar; 18(3):203-18. PubMed ID: 5473222
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of hyperlipidemia with the ethyl-ester of chlorophenoxyisobutyrate and androsterone.
    Schatz IJ
    Henry Ford Hosp Med J; 1965 Dec; 13(4):447-56. PubMed ID: 5325188
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia].
    De Gennes JL; Maunand B; Salmon D; Laudat P; Truffert J
    Rev Atheroscler (Paris); 1966; 8(1):27-52. PubMed ID: 5961027
    [No Abstract]   [Full Text] [Related]  

  • 27. Foam cells in the renal glomerulus.
    McKenzie IF; Kincaid-Smith P
    J Pathol; 1969 Jan; 97(1):151-4. PubMed ID: 5783631
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of chlorophenoxy-isobutyric ester on platelet adhesiveness and aggregation in the patients with arteriosclerosis and diabetes mellitus].
    Yasunaga K
    Naika Hokan; 1969 Oct; 16(10):393-403. PubMed ID: 5391800
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of clofibrate on serum lipids in atherosclerosis].
    Gietz E
    Med Klin; 1967 Mar; 62(9):336-8 passim. PubMed ID: 5593571
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of diet changes and use of dextrothyroxine and chlorphenisate on serum lipids].
    Arteaga A; Cisternas H; Torres MC; Alliende ME
    Rev Med Chil; 1969 May; 97(5):285-90. PubMed ID: 5386042
    [No Abstract]   [Full Text] [Related]  

  • 31. Pre-beta lipoproteinemia. Its bearing on the dietary management of serum lipid disorders as related to ischemic heart disease.
    Brown DF; Doyle JT
    Am J Clin Nutr; 1967 Apr; 20(4):324-32. PubMed ID: 6022009
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies on lipemia in elderly persons and the lipid lowering effect of a clofibrate derivate in 2 groups of test persons].
    Rilliet B; Monnier J
    Praxis; 1969 Jun; 58(25):815-20. PubMed ID: 5819485
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical experimentation with CPIB (with or without androsterone) in the treatment of hyperlipemia. Apropos of 35 cases].
    Warembourg H; Jaillard J
    Lille Med; 1965 Apr; 10(4):431-6. PubMed ID: 5318637
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antilipidemic activity of ethyl-chloro-phenoxy-isobutyrate or clofibrate].
    Barisone D; Gallo G; Accardo S
    Minerva Med; 1969 Jan; 60(6):174-80. PubMed ID: 5776766
    [No Abstract]   [Full Text] [Related]  

  • 35. Divergent effects in the treatment of hyperlipemia.
    Slowe IA; Carter AC; Feldman EB
    Arch Intern Med; 1965 Oct; 116(4):523-30. PubMed ID: 5835355
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of ethyl alpha-p-chlorophenoxyisobutyrate (Clofibrate) on lipids, cholesterol and uric acid in diabetes mellitus].
    Orsetti A; Mirouze J
    Therapie; 1966; 21(3):685-91. PubMed ID: 5942133
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect on serum tocopherol levels of drug-induced decrease in serum lipids.
    Weiss P; Bianchine JR
    Am J Med Sci; 1969 Oct; 258(4):275-81. PubMed ID: 5823464
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diurnal activity rhythm of HMG-CoA reductase and decrease of lipid levels].
    Mertz DP; Göhmann E; Suermann I; Eisele R; Schatton W
    Med Welt; 1982 Mar; 33(11):405-7. PubMed ID: 7201059
    [No Abstract]   [Full Text] [Related]  

  • 39. The in vitro effect of clofibrate on platelet aggregation.
    Davis JW; Wilson SJ; McField JR
    Am J Med Sci; 1966 Dec; 252(6):697-700. PubMed ID: 5954672
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of chlorophenoxyisobutyric acid ester with androsterone on plasma lipids in women.
    DENBOROUGH MA; LOVELL RR; TREVAKS G
    Med J Aust; 1963 Apr; 50(1)():498-501. PubMed ID: 14026953
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.